WeirFoulds represents Antibe Therapeutics in a $40M public offering
On February 24, 2020, Antibe Therapeutics Inc. (“Antibe”) (TSX: ATE) announced that it closed a bought deal public offering of 6,727,500 units (the “Units”) raising aggregate gross…